Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib Study of Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain

NCT02078089 is registered in ClinicalTrials.gov with Costantine Albany as lead sponsor.

NCT NCT02078089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02078089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib Study of Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain
Lead sponsor
Costantine Albany
Phase
Phase 1
Overall status
Terminated
Start date
March 6, 2014
Completion date
December 11, 2014
Enrollment
1 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer